menu
    • menu

    Company profile for Dabur Research Foundation

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dabur Research Foundation (DRF) is an Indian Contract Research Organization offering pre-clinical services in Drug Discovery and Development, ranging from identification of potential lead molecules, drug development to IND enabling studies. We offer pre-clinical services to global Biotech, Pharma, Phytopharmaceuticals Cosmescuticals and academia sectors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dabur Research Foundationindia-flag Flag
    Country
    Country
    India
    Address
    Address
    22, Site IV, Sahibabad Ghaziabad - 201010 Uttar Pradesh
    Telephone
    Telephone
    +91-0120-3378990
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.daburresearch.in/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dabur-research-foundation/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dabur India Reports Consolidated Q2 FY26 PAT At Rs. 452.55 Cr
    Dabur India Reports Consolidated Q2 FY26 PAT At Rs. 452.55 Cr

    02 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/dabur-india-reports-consolidated-q2-fy26-pat-at-rs-45255-cr-18129

    INDPHARMAPOST
    02 Nov 2025
    Share Share
    NewU Partners with Unicommerce for Omnichannel Operations
    NewU Partners with Unicommerce for Omnichannel Operations

    10 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/supply-chain/daburs-newu-signs-unicommerce-to-power-its-omnichannel-operations-17764

    INDPHARMAPOST
    10 Sep 2025
    Share Share
    Dabur India posts Q4 FY25 consolidated PAT at Rs. 320.13 Cr
    Dabur India posts Q4 FY25 consolidated PAT at Rs. 320.13 Cr

    12 May 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/dabur-india-posts-q4-fy25-consolidated-pat-at-rs-32013-cr-17134

    INDPHARMAPOST
    12 May 2025
    Share Share
    Dabur appoints Sriram Padmanabhan as Head of Health Care Business
    Dabur appoints Sriram Padmanabhan as Head of Health Care Business

    14 Apr 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/people/dabur-appoints-sriram-padmanabhan-as-head-of-health-care-business-17017

    INDPHARMAPOST
    14 Apr 2025
    Share Share
    Dabur Q1 FY25 consolidated net profit up 8% at Rs 500 Cr
    Dabur Q1 FY25 consolidated net profit up 8% at Rs 500 Cr

    01 Aug 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/news/dabur-q1-fy25-consolidated-net-profit-up-8-at-rs-500-cr-15963

    INDIANPHARMAPOST
    01 Aug 2024
    Share Share
    Dabur India updates on Q1 FY25
    Dabur India updates on Q1 FY25

    06 Jul 2024

    // INDIAPHARMAPOST

    https://www.indianpharmapost.com/news/dabur-india-updates-on-q1-fy25-15847

    INDIAPHARMAPOST
    06 Jul 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    Others

    read-more
    read-more

    ABOUT THIS PAGE

    Contact Dabur Research Foundation and get a quotation

    Dabur Research Foundation is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of MANUFACTURING SITE FACILITIES OPERATING PROCEDURES AND PERSONEL FOR MFG OF METAXALONE IN KALYANI DIST NADIA WEST BENGAL INDIA bulk offered by Dabur Research Foundation

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search